More

    NeurologyLive® Brain Games: September 17, 2023


    Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.

    Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.

    This week’s questions include the theme of Alzheimer disease and dementia.

    Click here to check out the prior iterations of Brain Games.

    Interested in submitting quiz questions? Contact our associate editorial director, Matt Hoffman, via email: [email protected].

    Which genetic mutation is most strongly associated with the development of early-onset familial Alzheimer’s disease (EOFAD)?

    Which cerebrospinal fluid biomarker is indicative of Alzheimer disease pathology and is often used in research and clinical trials to aid in early diagnosis and monitoring of the disease?

    In the treatment of behavioral and psychological symptoms of dementia, which atypical antipsychotic medication should be used with caution due to an increased risk of cerebrovascular events in elderly patients with dementia?

    How did you do on this week’s quiz? Let us know with a response to the poll below. Don’t forget to share and compare your results with your friends!

    How many questions did you get correct?



    Source link

    Latest articles

    Related articles

    Discover more from Blog | News | Travel

    Subscribe now to keep reading and get access to the full archive.

    Continue reading